Related references
Note: Only part of the references are listed.Dimethylarginine Dimethylaminohydrolase-1 Is the Critical Enzyme for Degrading the Cardiovascular Risk Factor Asymmetrical Dimethylarginine
Xinli Hu et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Asymmetric Dimethylarginine, Endothelial Nitric Oxide Bioavailability and Mortality in Sepsis
Joshua S. Davis et al.
PLOS ONE (2011)
Sequence Variation in DDAH1 and DDAH2 Genes Is Strongly and Additively Associated with Serum ADMA Concentrations in Individuals with Type 2 Diabetes
Sotoodeh Abhary et al.
PLOS ONE (2010)
Vasoactive-inotropic score as a predictor of morbidity and mortality in infants after cardiopulmonary bypass
Michael G. Gaies et al.
PEDIATRIC CRITICAL CARE MEDICINE (2010)
Increased Asymmetric Dimethylarginine in Severe Falciparum Malaria: Association with Impaired Nitric Oxide Bioavailability and Fatal Outcome
Tsin W. Yeo et al.
PLOS PATHOGENS (2010)
Common genetic variation in DDAH2 is associated with intracerebral haemorrhage in a Chinese population: a multi-centre case-control study in China
Yongyi Bai et al.
CLINICAL SCIENCE (2009)
Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine
Joe Brierley et al.
CRITICAL CARE MEDICINE (2009)
Methylated arginine derivatives in children and adolescents with chronic kidney disease
Ellen R. Brooks et al.
PEDIATRIC NEPHROLOGY (2009)
Polymorphisms in the promoter region of the dimethylarginine dimethylaminohydrolase 2 gene are associated with prevalence of hypertension
Renke Maas et al.
PHARMACOLOGICAL RESEARCH (2009)
Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008
R. Phillip Dellinger et al.
CRITICAL CARE MEDICINE (2008)
Distinct hemodynamic patterns of septic shock at presentation to pediatric intensive care
Joe Brierley et al.
PEDIATRICS (2008)
Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems
Fredrik Palm et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Isoform-specific regulation by NG, NG-dimethylarginine dimethylaminohydrolase of rat serum asymmetric dimethylarginine and vascular endothelium-derived relaxing factor/NO
Dan Wang et al.
CIRCULATION RESEARCH (2007)
Asymmetric dimethylarginine (ADMA) in vascular, renal and hepatic disease and the regulatory role of L-arginine on its metabolism
David E. L. Wilcken et al.
MOLECULAR GENETICS AND METABOLISM (2007)
Dimethylarginine dimethylaminohydrolase-2 overexpression improves impaired nitric oxide synthesis of endothelial cells induced by glycated protein
Chang-Wu Lu et al.
NITRIC OXIDE-BIOLOGY AND CHEMISTRY (2007)
Measurement of arginine derivatives in pediatric patients with chronic kidney disease using high-performance liquid chromatography-tandem mass spectrometry
Sihe Wang et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2007)
L-arginine regulates asymmetric dimethylarginine metabolism by inhibiting dimethylarginine dimethylaminohydrolase activity in hepatic (HepG2) cells
J. Wang et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2006)
Gene polymorphism and requirement for vasopressor infusion after cardiac surgery
Ronan Ryan et al.
ANNALS OF THORACIC SURGERY (2006)
Asymmetric dimethylarginine is an independent risk factor for coronary heart disease:: Results from the multicenter coronary artery risk determination investigating the influence of ADMA concentration (CARDIAC) study
Friedrich Schulze et al.
AMERICAN HEART JOURNAL (2006)
Septic shock is correlated with asymmetrical dimethyl arginine levels, which may be influenced by a polymorphism in the dimethylarginine dimethylaminohydrolase II gene: a prospective observational study
Michael J. O'Dwyer et al.
CRITICAL CARE (2006)
Haplotypic association of DDAH1 with susceptibility to pre-eclampsia
F Akbar et al.
MOLECULAR HUMAN REPRODUCTION (2005)
Elevated levels of asymmetric dimethylarginine (ADMA) as a marker of cardiovascular disease and mortality
RH Boger et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2005)
Dimethylarginine dimethylaminohydrolase regulates nitric oxide synthesis - Genetic and physiological evidence
H Dayoub et al.
CIRCULATION (2003)
Common genetic variation in a basal promoter element alters DDAH2 expression in endothelial cells
LC Jones et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Validation of the paediatric logistic organ dysfunction (PELOD) score: prospective, observational, multicentre study
S Leteurtre et al.
LANCET (2003)
PIM2: a revised version of the Paediatric Index of Mortality
A Slater et al.
INTENSIVE CARE MEDICINE (2003)
Asymmetrical dimethylarginine (ADMA) in critically ill patients: high plasma ADMA concentration is an independent risk factor of ICU mortality
RJ Nijveldt et al.
CLINICAL NUTRITION (2003)
Arginine and nitric oxide metabolism in critically ill septic pediatric patients
Z Argaman et al.
CRITICAL CARE MEDICINE (2003)
The DDAH/ADMA/NOS pathway
CTL Tran et al.
ATHEROSCLEROSIS SUPPLEMENTS (2003)
S-nitrosylation of dimethylarginine dimethylaminohydrolase regulates enzyme activity:: Further interactions between nitric oxide synthase and dimethylarginine dimethylaminohydrolase
J Leiper et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Effects of nitric oxide in septic shock
JL Vincent et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)
Asymmetric dimethylarginine increases mononuclear cell adhesiveness in hypercholesterolemic humans
JR Chan et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
Share Paper
